Determining when antibiotics should be used in treating gum disease
Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practice: A PBRN Clinical Trial
This study is looking at how and when dentists should use antibiotics to help treat gum disease, aiming to make sure patients get the best care while also preventing antibiotic resistance.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-10897107 on NIH RePORTER |
What this research studies
This research investigates the appropriate use of adjunctive antibiotics in the treatment of periodontal disease, which affects a significant portion of adults. It aims to establish clear guidelines for dentists on when antibiotics should be prescribed to enhance treatment outcomes while minimizing the risk of antibiotic resistance. By analyzing patient data and treatment results, the study seeks to identify specific cases where antibiotics can effectively aid in managing periodontal infections. The goal is to improve patient care and ensure that antibiotics are used judiciously in dental practices.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are diagnosed with chronic periodontitis and may require antibiotic treatment.
Not a fit: Patients with periodontal disease who are not candidates for antibiotic therapy or those who do not meet the study criteria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better treatment protocols for periodontal disease, ultimately improving oral health and reducing tooth loss for patients.
How similar studies have performed: Previous research has shown varying success in the use of antibiotics for periodontal treatment, indicating a need for more definitive guidelines in this area.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Kotsakis, Georgios — Rutgers Biomedical and Health Sciences
- Study coordinator: Kotsakis, Georgios
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.